ALK and non-small cell lung carcinoma: Mutations of several pathways in NSCLC upregulate PD-L1 expression to achieve immune escape, including EGFR pathway, ALK pathway, RAS/RAF/MAPK pathway, EMT, MYC, and mTOR.